Getting a promising new topical product from lab to patient is challenging. Making it all the way through the development pipeline will be time-consuming, risky, and unpredictable. That’s why it makes sense to think ahead and partner with the topical experts that can give pharma companies like yours more opportunities for success, every step of the way. As a CDMO focused on topical dosage forms, Tergus has the proven ability to understand and anticipate the needs of our partners—even in the face of market changes, regulatory environments, or corporate strategy. Whether through our unrivaled expertise in R&D, providing clinical trial material manufacturing, and now the addition of full-scale commercial manufacturing, we are eager to support every aspect of your topical drug pipeline. Let’s work together. Because getting there starts here.
External link for Tergus Pharma
4018 Stirrup Creek Dr
Durham, NC 27703, US
Here in Philly with my colleague Tim Miley, ready to talk about Tergus' CDMO services!
We’re open for business at CPHI North America in Philadelphia! Come by booth 642 to talk about how Tergus can support your topical drug development and commercial production. #TeamTergus #TergusCDMO #CPHINorthAmerica
We’re open for business at CPHI North America in Philadelphia! Come by booth 642 to talk about how Tergus can support your topical drug development and commercial production. #TeamTergus #TergusCDMO #CPHINorthAmerica
CPhI North America 2024 is here! Don’t miss a great opportunity to discuss your topical product with the topical experts at Booth #642! #CPhINorthAmerica #TopicalCDMO #TopicalDrugDevelopment #TopicalManufacturing
Did you know that Tergus has a purpose-built, cGMP, full-commercial production facility for topical products, including batch sizes from 30L to 1500L, separate dedicated HPAPI and hormone suites, and packaging capabilities for full turnkey CMO services? Let’s talk about it at CPhI North America next week, Booth #642. #CPhINorthAmerica #TopicalCDMO #TopicalDrugDevelopment #TopicalProduction
CPhI North America is a week away, so let’s schedule a meeting at our Booth #642 to discover how Tergus can put our unrivaled expertise in early- & late-stage R&D and full-scale commercial production to work for your topical product program. #CPhINorthAmerica #TopicalCDMO #TopicalDrugDevelopment #TopicalManufacturing
Did you know that April is Rosacea Awareness Month? Rosacea is a common skin condition effecting 415+ million people around the world. Rosacea causes flushing or long-term redness on the face. Symptoms can come and go, with flare-ups lasting for weeks or months. While there is no cure, symptoms can be controlled with medical therapy. As a leader in the development and manufacture of topical treatments, Tergus is committed to helping our clients find new products to treat this disease. https://hubs.la/Q02qYPyY0 #Rosacea #RosaceaAwarenessMonth #topicalformulations #topicalmanufacturing
DCAT Week 2024 is here! Don’t miss a great opportunity to discuss your topical product with the topical experts! https://hubs.la/Q02jpfVV0 #DCATWeek2024 #TopicalCDMO #TopicalDrugDevelopment #TopicalProduction
We’re rolling out the red carpet for our meeting guests at the Lotte New York Palace during DCAT Week next week. If you have a topical drug product in your portfolio, we should talk. https://hubs.la/Q02jpfWF0 #DCATWeek2024 #TopicalCDMO #TopicalDrugDevelopment #TopicalProduction
Ready to kick off the AID Dermatology Innovation Forum today in San Diego as a proud AID sponsor. #AIDDermatologyInnovationForum2024 #TopicalCDMO #TopicalDrugDevelopment #TopicalFormulation #TopicalProduction
Did you know that Tergus has a purpose-built, cGMP, full-commercial production facility for topical products, including batch sizes from 30L to 1500L, separate dedicated HPAPI and hormone suites, and packaging capabilities for full turnkey services? Let’s talk about it during DCAT week. https://hubs.la/Q02jn6mP0 #DCATWeek2024 #TopicalCDMO #TopicalDrugDevelopment #TopicalProduction